International Journal of Innovative Technologies in Social Science
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally developed for the treatment of type 2 diabetes mellitus and obesity, are increasingly being investigated for their
International Journal of Innovative Technologies in Social Science
Chronic pain syndromes remain a major clinical and public health challenge because of their multifactorial pathophysiology, frequent refractoriness to standard treatment, and marke
International Journal of Innovative Technologies in Social Science
Endometriosis is a chronic, estrogen-dependent inflammatory disease affecting approximately 10% of women of reproductive age and is one of the leading causes of chronic pelvic pain
International Journal of Innovative Technologies in Social Science
Oncoplastic breast surgery is a rapidly evolving field that combines oncologic surgery with plastic and reconstructive surgery. From the perspective of oncologic surgery, the prima
International Journal of Innovative Technologies in Social Science
One of the most widespread liver diseases in the world is metabolic dysfunction-associated steatotic liver disease (MASLD), known until recently as non-alcoholic fatty liver diseas
International Journal of Innovative Technologies in Social Science
The epidemiology of performance- and image-enhancing drug (PIED) use has shifted toward non-athlete recreational users who primarily seek cosmetic physical changes. This review eva
International Journal of Innovative Technologies in Social Science
Background: Cardiometabolic diseases (CMD), including obesity, hypertension, and metabolic syndrome (MS), are increasingly prevalent in pediatric populations. Early identification